Literature DB >> 26528278

Characterization of CTX-M-14-producing Escherichia coli from food-producing animals.

Xiao-Ping Liao1, Jing Xia1, Lei Yang1, Liang Li1, Jian Sun1, Ya-Hong Liu2, Hong-Xia Jiang1.   

Abstract

Bacterial resistance to the third-generation cephalosporin antibiotics has become a major concern for public health. This study was aimed to determine the characteristics and distribution of bla CTX-M-14, which encodes an extended-spectrum β-lactamase, in Escherichia coli isolated from Guangdong Province, China. A total of 979 E. coli isolates isolated from healthy or diseased food-producing animals including swine and avian were examined for bla CTX-M-14 and then the bla CTX-M-14 -positive isolates were detected by other resistance determinants [extended-spectrum β-lactamase genes, plasmid-mediated quinolone resistance, rmtB, and floR] and analyzed by phylogenetic grouping analysis, PCR-based plasmid replicon typing, multilocus sequence typing, and plasmid analysis. The genetic environments of bla CTX-M-14 were also determined by PCR. The results showed that fourteen CTX-M-14-producing E. coli were identified, belonging to groups A (7/14), B1 (4/14), and D (3/14). The most predominant resistance gene was bla TEM (n = 8), followed by floR (n = 7), oqxA (n = 3), aac(6')-1b-cr (n = 2), and rmtB (n = 1). Plasmids carrying bla CTX-M-14 were classified to IncK, IncHI2, IncHI1, IncN, IncFIB, IncF or IncI1, ranged from about 30 to 200 kb, and with insertion sequence of ISEcp1, IS26, or ORF513 located upstream and IS903 downstream of bla CTX-M-14. The result of multilocus sequence typing showed that 14 isolates had 11 STs, and the 11 STs belonged to five groups. Many of the identified sequence types are reported to be common in E. coli isolates associated with extraintestinal infections in humans, suggesting possible transmission of bla CTX-M-14 between animals and humans. The difference in the flanking sequences of bla CTX-M-14 between the 2009 isolates and the early ones suggests that the resistance gene context continues to evolve in E. coli of food producing animals.

Entities:  

Keywords:  CTX-M-14; Escherichia coli; MLST; cephalosporin; plasmids

Year:  2015        PMID: 26528278      PMCID: PMC4606122          DOI: 10.3389/fmicb.2015.01136

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


Introduction

Enterobacteria with resistance to third and fourth generation cephalosporin antibiotics, especially Escherichia coli bearing extended-spectrum β-lactamase genes (ESBLs), have been detected in a wide range of food-producing animals. In 1989, CTX-M-type β-lactamases, whose carriers are highly resistant to cefotaxime but sometimes susceptible to ceftazidime, were considered as a novel group of class-A β-lactamases with extended-spectrum properties. This family of enzymes are well inhibited by clavulanate and tazobactam (Tzouvelekis et al., 2000). Since then, the CTX-M family of ESBLs has become prominent and is common in E. coli with many infections occurring in human patients in the community (Livermore and Hawkey, 2005). In addition, the occurrence and prevalence of CTX-M in food-producing animals were also reported frequently (Hammerum et al., 2012; Reich et al., 2013). Rapid dissemination of blaCTX-M genes involved plasmids and mobile genetic elements as well as epidemic spread of particular strains (Eckert et al., 2006). ISEcp1-like insertion sequences (ISs) have repeatedly been observed upstream of open reading frames (ORFs) encoding members belonging to the CTX-M-1, CTX-M-2, and CTX-M-9 clusters. ISs such as IS10, IS26, and IS903 have also been observed flanking the ORF region of blaCTX-M genes (Arduino et al., 2002). Of the CTX-M enzymes, the CTX-M-1 and CTX-M-9 clusters have been the most frequently reported worldwide, and although in some places CTX-M-2 group remains endemic, the emergence of new CTX-M groups (mainly CTX-M-1 and CTX-M-9) has been documented (D’Andrea et al., 2013). In addition, the CTX-M-14 enzyme is, besides CTX-M-9, the most widespread enzyme of the CTX-M-9 group (Valverde et al., 2009), especially in China (Li et al., 2010; Zheng et al., 2012). CTX-M-14 was first isolated from hospital in China in 1997 (Chanawong et al., 2002). It is a member of the CTX-M-9 cluster and differs from blaCTX-M-9 only by the substitution Ala 231→Val (Ma et al., 2002), and it has spread almost all over the world (Canton and Coque, 2006). Reports showed that ISEcp1, IS26, ORF513, IS903, and ORF1005 located upstream and downstream of blaCTX-M-14, respectively, which might have contributed to its widespread transmission (Izumiya et al., 2005; Eckert et al., 2006; Bae et al., 2007; Navarro et al., 2007). Moreover, most of the literature indicates that novel CTX-M enzyme genes were often derived from or recombinated with CTX-M-14-like β-lactamase (Djamdjian et al., 2011; He et al., 2013; Tian et al., 2014), indicating that blaCTX-M genes evolve by homologous recombination between members of different groups, especially with blaCTX-M-14 (Tian et al., 2014). Due to the importance of blaCTX-M-14 in antimicrobial resistance and its limited information in food producing animals, we examined the characteristics and distribution of blaCTX-M-14 in E. coli of food-producing animals in China in this study.

Materials and Methods

Bacterial Isolates and CTX-M-14 Detection

From 2002 to 2009, a total of 979 E. coli isolates, including 455 isolates in 2002, 119 isolates in 2003–2004, 76 isolates in 2007 and 329 isolates in 2009 were isolated from healthy or diseased food-producing animals from Guangdong Province in China. Samples were collected from rectal swabs of healthy animals, or the liver, heart, lung, or muscle samples of diseased or dead animals. Samples were seeded on MacConkey agar at 37°C, and one colony with typical E. coli morphology was selected from each sample. Each isolate was from an individual animal. The bacterial strains were identified by classical biochemical methods and confirmed using the API-20E system (bioMérieux). All confirmed E. coli isolates were stored at -80°C in the Luria–Bertani broth medium containing 30% glycerol. Cefotaxime-resistant E. coli isolates were selected on MacConkey agar containing cefotaxime at 2 μg/mL and then the blaCTX-M-14 gene was detected by PCR analysis with the primer described previously (Yu et al., 2007), the primers and PCR programs were listed in Supplementary Table S1. PCR products were directly sequenced, and then made comparison in the GenBank nucleotide database.

Antimicrobial Susceptibility Testing and Genes Characterization

The minimum inhibitory concentrations (MICs) of quinolones (nalidixic acid), fluoroquinolones (ciprofloxacin, enrofloxacin, and levofloxacin), third-generation cephalosporins (ceftiofur, cefotaxime, and ceftazidime) and other antimicrobials (olaquindox, ampicillin, trimethoprim-sulfamethoxazole, tetracycline, gentamicin, amikacin, chloramphenicol, and florfenicol) in blaCTX-M-14 positive isolates were determined by the agar dilution method following the CLSI guidelines. The breakpoints for individual antimicrobial were used as recommended by the CLSI (M100-S19), CLSI (Vet01-A4/Vet01-S2), and DANMAP 98 (olaquindox). E. coli ATCC25922 was used as a quality control strain. All blaCTX-M-14 positive isolates were tested for blaCTX-M-1G, blaCTX-M-2G, blaCTX-M-8G, blaTEM, and blaSHV, blaOXA and blaCMY -2 by PCR and then confirmed by sequencing. At the same time, plasmid-mediated quinolone resistance (PMQR) genes (qnrA, qnrB, qnrC, qnrD, qnrS, qepA, aac(6′)-Ib-cr, and oqxA), rmtB and floR were also detected. The PCR programs and primer sequences were described previously (Yu et al., 2007; Yue et al., 2008; Veldman et al., 2011; Li et al., 2013; Liu et al., 2013, 2014). The primers and PCR programs were listed in Supplementary Table S1. All PCR products were directly sequenced, and the results were compared with those in the GenBank nucleotide database.

Clonal Relatedness

A multiplex PCR methodology was employed to assign isolates harboring blaCTX-M-14 to one of the four phylogenetic groups (A, B1, B2, or D). Primers and methodology have been described previously (Doumith et al., 2012). For isolates carrying blaCTX-M-14, multilocus sequence typing (MLST) was performed using seven conserved housekeeping genes (adk, purA, recA, mdh, icd, gyrB, and fumC; Wirth et al., 2006). The internal fragments of all loci were sequenced. Allelic profiles and sequence type (ST) determinations were performed according to the E. coli MLST website[1] scheme. MLST data were analyzed by using the eBURST program (version 3[2]), which assesses the relationship within clonal complexes. The set minimum group allele number was five. The UPGMA method of START program (version 2) was used to construct phylogenetic grouping tree. The genetic distance is 0.1.

Transfer of the bla Gene and Plasmid Analysis

Transferability of the identified blaCTX-M-14 genes was determined by conjugation using streptomycin-resistant E. coli C600 as the recipient strain (Zheng et al., 2012). Transconjugants were selected on MacConkey agar plates supplemented with cefotaxime (2 μg/mL) and streptomycin (2000 μg/mL). For those isolates that failed in conjugation experiments, plasmid DNA was extracted by QIAGENPrep Plasmid Midi Kit (Qiagen, Germany), and electroporated into electrocompetent E. coli DH5α (TaKaRa Biotechnology, Dalian, China) using a Gene Pulser apparatus (Biorad Laboratories). Transformants were selected on MacConkey agar plates supplemented with cefotaxime (2 μg/mL). The presence of blaCTX-M-14 was confirmed by PCR. Plasmids were preliminarily classified according to their incompatibility group by using the PCR-based replicon typing (PBRT) scheme described previously (Carattoli et al., 2005). PFGE with S1 nuclease (TakaRa Biotechnology, Dalian, China) digestion of whole genomic DNA was performed for all 14 transconjugants and transformants as described previously (Barton et al., 1995). After Southern transfer to a Hybond-N+ membrane (GE Healthcare, Little Chalfont, UK), the plasmids were probed with the blaCTX-M-9G gene (DIG High Prime DNA Labeling and Detection Starter Kit I, Roche Applied Science, Mannheim, Germany).

Genetic Environment of bla

Detection of the ISs including ISEcp1, IS26, ORF513, IS903, and ORF1005, which are located upstream or downstream of blaCTX-M-14, were performed by PCR according to the methods in previous reports (Izumiya et al., 2005; Eckert et al., 2006; Bae et al., 2007; Navarro et al., 2007; Barlow et al., 2008).

Results

Antimicrobial Susceptibility and Detection of Resistance Genes

Among the 979 E. coli isolates surveyed, fourteen isolates harbored blaCTX-M-14, among which four were isolated from swine in 2002, two from duck in 2005 and 2007, and the other eight were isolated from swine and duck in 2009. All the 14 blaCTX-M-14-positive isolates were multidrug resistant (resistant to three or more classes of antimicrobials) and all of them were resistant to ampicillin, cefotaxime, ceftiofur, ceftriaxone, florfenicol, tetracycline, kanamycin, and ciprofloxacin. In addition, the resistance of the blaCTX-M-14-positive isolates to gentamicin and doxycycline were 64 and 86%, respectively (Table ). Among the fourteen isolates harboring blaCTX-M-14, only one isolate was confirmed as blaCTX-M-14b-carrying strain, the other thirteen were blaCTX-M-14a. In addition, the fourteen isolates were also subjected to the detection of ESBLs, PMQR genes and other resistance genes (rmtB and floR). The most predominant gene was blaTEM (n = 8), including six blaTEM-1, one blaTEM-1b, and one blaTEM-135, followed by floR (n = 7), oqxA (n = 3), aac(6′)-1b-cr (n = 2), and rmtB (n = 1) (Table ). Characteristics of the 14 Escherichia coli isolates carrying blaCTX-M-14.

Clonal Relatedness and Transfer of bla

Phylogenetic group analysis showed that group A (7/14) was dominant amongst the isolates that produced the CTX-M-14 enzymes, followed by group B1 (4/14) and group D (3/14). None of them belonged to group B2 (Table ). The result of MLST showed that the 14 isolates have 11 ST, among which ST2929 and ST2962 were newly discovered (Supplementary Table S2). The MLST results belonged to five groups. ST10, ST206, ST2929, ST2930, and ST2962 belonged to Group 1 (Figure ), while ST155, ST224, and ST602 were classified into Group 2 (Figure ). Furthermore, ST648, ST359, and ST405 belonged to Group14, Group16, and Group17, respectively. Phylogenetic grouping tree suggested that ST10, ST2929, ST206, and ST2930 were close in one branch, while ST224, ST602, ST155, ST359, and ST2962 were clustered in another branch. ST648 and ST405 were separated from others (Figure ). Eight transconjugants and six transformants were successfully obtained by conjugation/transformation experiments. Co-transfer of blaTEM-1 or rmtB or floR genes were also detected. The blaCTX-M-14-positive strain isolated in 2005 co-transferred with blaTEM-1. Among the 2009 isolates, one had co-transfer of rmtB, two had co-transfer of floR, and another one had co-transfer of both blaTEM-1 and rmtB. MICs of cefotaxime, ceftiofur, and ceftriaxone increased two–fourfold compared with the recipients. (A) eBRUST results of Group 1. The red boxes indicate that the corresponding five sequence types (STs ; ST206, ST10, ST2929, ST2930, and ST2962) we detected in Group 1. (B) eBRUST results of Group 2. The red boxes indicate that the corresponding three STs (ST155, ST224, and ST602) we detected in Group 2. Evolutionary branches of 14 .

Plasmids and Genetic Environment of bla

Plasmids containing blaCTX-M-14 were predominately belonging to IncF (n = 5), IncK (n = 3), and lncI1 (n = 2). Additionally, 2 of the 14 were positive for two replicons (IncHI1 and IncN), another one was positive for IncFIB and IncF, and the remaining one belonged to lncHI2 and lncF. The size of the plasmids ranged from about 30 to 200 kb (Supplementary Figure S2). ISEcp1 and IS903 were found upstream and downstream, respectively, of the blaCTX-M-14-positive isolates isolated from 2002 to 2007(Supplementary Figure S1). Among the eight positive isolates isolated in 2009, four were detected with ISEcp1 and IS903 upstream and downstream, respectively, one harbored ISEcp1 upstream, and the other three carried IS903 downstream. In addition, IS26 was confirmed in one strain of 2009, and ORF513 positive isolates were also found in this year. None of the isolates harbored ORF1005.

Discussion

CTX-M-type ESBLs, with 150 variants, have recently been the most widespread ESBLs in E. coli. CTX-M variants can be divided into six clusters: the CTX-M-1, -2, -8, -9, -25, and KLUC groups. Additionally, the most frequently reported groups are CTX-M-1 and CTX-M-9, and CTX-M-14 is the most variant within the latter group (D’Andrea et al., 2013). In this study, phylogenetic group analysis showed that group A (7/14) was dominant amongst the isolates that produced the CTX-M-14 enzymes, followed by group B1 (4/14) and group D (3/14), which was consistent with the reports in Portugal, Spain, and China (Valverde et al., 2009; Zheng et al., 2012). Previous studies showed that most E. coli strains responsible for urinary tract infections and other extraintestinal infections in humans belong to group B2 or, to a lesser extent, to group D (Johnson and Stell, 2000; Yang et al., 2012). Investigation of urinary E. coli isolates from 20 widely dispersed tertiary Chinese hospitals revealed although phylogroups D and B2 were most frequently observed, phylogroups A and B1 were also found in blaCTX-M-14-producing E. coli isolates (Cao et al., 2011). According to recent reports, replicon types of blaCTX-M-14-positive plasmids belonged to lncF, lncFIB, lncI1, lncA/C, lncN, lncFII, and lncI1-Iγ (Millan et al., 2011; Song et al., 2011; Tamang et al., 2011). In this study, blaCTX-M-14-carrying plasmids predominately belonged to IncF and IncK. The spread of blaCTX-M-14 in E. coli in Spain is reported to be mediated by IncK plasmids (Valverde et al., 2009), while in Korea and France blaCTX-M-14 is mostly carried on IncF plasmids (Marcade et al., 2009). IncF plasmids were found frequently to be associated with CTX-M enzyme genes of E. coli (Matsumura et al., 2013; Mnif et al., 2013). IncK plasmids may facilitate the ability of E. coli to colonize the intestine and, consequently, enhance the pathogenic profile of specific clones or clonal groups (Oshima et al., 2008). Besides, reports showed that the acquisition of IncK plasmids containing blaCTX-M-14 by group A and B1 E. coli clones could have enhanced their ability to colonize the urinary tract in patients exposed to antibiotics (Valverde et al., 2009). IncHI1, IncHI2 and IncN plasmids were rarely reported in blaCTX-M-14-producing E. coli. In this study, 11 different STs (including two new STs) were detected among 14 blaCTX-M-14-producing E. coli isolates. The findings indicate that no ST predominates in CTX-M-14-producing E. coli from food-producing animals of Guangdong. ST10 and ST648 were common in E. coli isolated from human and animals (Shabana et al., 2013; Maluta et al., 2014; Xia et al., 2014; Jamborova et al., 2015). ST155 was once found in human, duck, and bovine (Ben Sallem et al., 2012; Sváb et al., 2013; Maluta et al., 2014). ST359 was once reported in human and duck (Maluta et al., 2014). ST405, a global clonal group associated with the global increase of ESBLs, was mainly reported in human origin as well as once reported in rooks and food origins (Jouini et al., 2013; Matsumura et al., 2014; Jamborova et al., 2015). ST602 in E. coli of cats was once reported (Nebbia et al., 2014). ST224 was detected in E. coli of human, dogs and buffalo origin (Mshana et al., 2011; Dahmen et al., 2013; Aizawa et al., 2014), while ST224 was found in duck origin in 2009 in this study[3]. Moreover, recent reports revealed that E. coli of human origin, especially E. coli-producing ESBLs associated with urinary tract infection, mainly belonged to the ST10 complex. In Portugal, Spain, and Brazil, ST155 and ST359 were found rising in patients suffering from urinary tract infection (Canton and Coque, 2006). In this study, the STs we have found were mainly reported in human, suggesting that blaCTX-M-14 could transfer between human and food-producing animals. Insertion sequences played an important role in the transfer of blaCTX-M-14. In this study, ISEcp1 was detected 42 nucleotides upstream of both blaCTX-M-14a and blaCTX-M-14b. It is of interest to note that an identical 42-bp region has also been detected upstream of different genes encoding ESBLs of the CTX-M-9 cluster, such as CTX-M-9, -14, -16, and -17 (Barlow et al., 2008), which means this subtype may have the same origin as blaCTX-M-14. From 2002 to 2007, the genetic environment of blaCTX-M-14-positive isolates was the same, with ISEcp1 and IS903 found upstream and downstream, respectively, while blaCTX-M-14-positive isolates in 2009 showed diversity of the genetic platform. IS26 and ORF513 were both found in 2009. It is important to note that ORF513 located upstream of blaCTX-M-14a in strain 16-D was the same as blaCTX-M-14b of strain 103-D. This showed that resistant genes of incompatible plasmids have the possibility to transfer and then recombine. Extended-spectrum β-lactamase genes genes were often found to be strongly associated with PMQR or 16S rRNA methyltransferase (16S-RMTase) genes, and some were often found to be located on the same plasmid, both in human and animals (Carattoli, 2009; Liu et al., 2013). In this study, blaCTX-M-14 of the isolates isolated from 2002 to 2007 tended to conjugate alone, while co-transfer with blaTEM-1, rmtB, or floR on the same plasmid were common in the 2009 isolates. Co-existence or co-spread of ESBLs with PMQR, rmtB or floR suggests that the resistant isolates could be selected by different classes of antibiotics. The fourteen isolates carrying blaCTX-M-14 were found to be multidrug resistant and showed resistance to more than two non-β-lactam antimicrobial agents, including kanamycin, tetracycline, doxycycline, nalidixic acid, ciprofloxacin, enrofloxacin, and florfenicol. Some of them were also resistant to other cephalosporins, including ceftiofur, cefoxitin, and ceftriaxone, but remained susceptible to ceftazidime fortunately. In addition, although the blaCTX-M-14-positive isolates showed resistance to kanamycin and gentamycin, most of them (13/14) remain susceptible to amikacin (data not shown), which indicated amikacin might be effective for treating blaCTX-M-14-positive E. coli infection.

Conclusion

The evolution of blaCTX-M-14 gradually became diversified in food-producing animals of Guangdong, China, from 2002 to 2009. Findings from this study and previous publications by others suggest that antibiotics, especially the third- and fourth-generation cephalosporins, should be used more prudently in food-producing animals.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Table 1

Characteristics of the 14 Escherichia coli isolates carrying blaCTX-M-14.

IsolatesOriginYearDrug-resistant spectrumGroupResistant genesMICs (μg/ml)
Replicon typingGenetic environment
CTFCTXCTR
ZLP20Pig2002AMP/CTX/CTR/CTF/KAN/DOX/TET/NAL/ENR/CIP/FLFAblaCTX-M-14a, oqxA, floR646464F, Y
ZLP20-DAMP/ CTR/CTF/CTXblaCTX-M-14a326464FISEcp1, IS903
ZLP19Pig2002AMP/CTX/CTR/CTF/KAN/DOX/TET/NAL/ENR/CIP/FLFAblaCTX-M-14a, floR6464128F, Y
ZLP19-DAMP/ CTX /CTR/CTFblaCTX-M-14a326464FISEcp1, IS903
ZLP21Pig2002AMP/CTX/CTR/CTF/KAN/GEN/DOX/TET/NAL/ENR/CIP/FLFAblaCTX-M-14a323264HI1, N
ZLP21-DAMP/ CTX /CTR/CTFblaCTX-M-14a323232HI1, NISEcp1, IS903
ZLP25Pig2002AMP/CTX/CTR/KAN/DOX/TET/NAL/ENR/CIP/FLFAblaCTX-M-14a, aac(6’)-1b-cr643264HI1, N
ZLP25-DAMP/ CTX /CTR/CTF/TETblaCTX-M-14a163216HI1, NISEcp1, IS903
HN428Duck2005AMP/CTR/CXT/CTF/KAN/SM/DOX/TET/NAL/ENR/CIP/FLFDblaCTX-M-14a, blaTEM-1643264FIB, FIC, I1, F
HN428-DAMP/ CTX /CTR /TETblaCTX-M-14a, blaTEM-14168FIB, FISEcp1, IS903
a88Duck2007AMP/CTR/CTF/KAN/SM/TET/NAL/ENR/CIP/ FLFDblaCTX-M-14a, blaTEM-1643264F, Y, K
a88-DAMP/ CTX /CTRblaCTX-M-14a41616FISEcp1, IS903
14Duck2009AMP/CTX/CTR/CXT/KAN/GEN/DOX/TET/NAL/ENR/CIP/FLFB1blaCTX-M-14a , blaCTX-M-79128256256I1, K
14-DAMP/ CTX /CTR/CTF/TETblaCTX-M-14a128256128KISEcp1, IS903
16Duck2009AMP/CTF/CTX/CTR/KAN/GEN/DOX/TET/NAL/ENR/CHL/CIP/FLFB1blaCTX-M-14a , blaTEM-135, oqxA, floR64128128HI2, FIB, K
16-DAMP/CTF/CTX/CTR/CHL/CIP/FLFblaCTX-M-14a6412832KORF513, IS903
40Duck2009AMP/CTX/CTR/KAN/GEN/DOX/TET/NAL/ENR/CIP/FLFAblaCTX-M-14a, blaTEM-1, oqxA, floR166464HI2, FIA, F, FIB
40-DAMP/CTF/CTX/CTR/GEN/FLFblaCTX-M-14a, floR16328HI2, FISEcp1, IS903
103Goose2009AMP/CTX/CTR/CXT/CTF/KAN/GEN/DOX/TET/NAL/ENR/CIP/FLFAblaCTX-M-14b , blaTEM-1, aac(6’)-1b-cr, rmtB6464128I1, FIB, F, K
103-DAMP/CTF/CTX/CTR/CHL/CIP/FLFblaCTX-M-14b, rmtB646464I1ISEcp1, ORF513, IS903
132Goose2009AMP/CTX/CTF/CTR/KAN/DOX/TET/NAL/ENR/CIP/FLFB1blaCTX-M-14a, oqxA, floR64256256P, F, K
132-DAMP/CTX/CTF/CTRblaCTX-M-14a6412832FIS903
156Pig2009AMP/CTF/CTX/CTR/KAN/GEN/DOX/TET/NAL/ENR/CIP/FLFDblaCTX-M-14a, blaTEM-1, floR12864128FIA,P, F, K
156-DAMP/CTF/CTX/CTR/KAN/GEN/DOX/TET/NAL/ENR/CIP/FLFblaCTX-M-14a, blaTEM-1, floR128256128KISEcp1, IS903
173Pig2009AMP/CTX/CTF/CTR/CTF/KAN/GEN/DOX/TET/NAL/ENR/CIP/FLFAblaCTX-M-14a, blaTEM-1, floR646464FIB, Y, F, K
173-DAMP/CTX/CTF/CTRblaCTX-M-14a, floR646464FIS26, ISEcp1, IS903
187Pig2009AMP/CTX/CTF/CTR/KAN/GEN/DOX/TET/NAL/ENR/CIP/FLFB1blaCTX-M-14a, blaTEM-1b326464FIB, I1, Y, F, K
187-DAMP/CTX/CTF/CTR/KAN/GEN/CIPblaCTX-M-14a166416I1IS903
  53 in total

1.  blaCTX-M-2 is located in an unusual class 1 integron (In35) which includes Orf513.

Authors:  Sonia M Arduino; Paul H Roy; George A Jacoby; Betina E Orman; Silvia A Pineiro; Daniela Centron
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

2.  Prevalence and characterisation of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia.

Authors:  R Ben Sallem; K Ben Slama; V Estepa; A Jouini; H Gharsa; N Klibi; Y Sáenz; F Ruiz-Larrea; A Boudabous; C Torres
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-08       Impact factor: 3.267

Review 3.  The CTX-M beta-lactamase pandemic.

Authors:  Rafael Cantón; Teresa M Coque
Journal:  Curr Opin Microbiol       Date:  2006-08-30       Impact factor: 7.934

4.  CTX-M-93, a CTX-M variant lacking penicillin hydrolytic activity.

Authors:  Laura Djamdjian; Thierry Naas; Didier Tandé; Gaelle Cuzon; Catherine Hanrotel-Saliou; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

5.  Identification of plasmids by PCR-based replicon typing.

Authors:  Alessandra Carattoli; Alessia Bertini; Laura Villa; Vincenzo Falbo; Katie L Hopkins; E John Threlfall
Journal:  J Microbiol Methods       Date:  2005-06-02       Impact factor: 2.363

6.  Plasmid-mediated resistance to cephalosporins and fluoroquinolones in various Escherichia coli sequence types isolated from rooks wintering in Europe.

Authors:  Ivana Jamborova; Monika Dolejska; Jiri Vojtech; Sebastian Guenther; Raluca Uricariu; Joanna Drozdowska; Ivo Papousek; Katerina Pasekova; Wlodzimierz Meissner; Jozef Hordowski; Alois Cizek; Ivan Literak
Journal:  Appl Environ Microbiol       Date:  2014-11-07       Impact factor: 4.792

7.  Characterization of blaCTX-M IncFII plasmids and clones of Escherichia coli from pets in France.

Authors:  Safia Dahmen; Marisa Haenni; Pierre Châtre; Jean-Yves Madec
Journal:  J Antimicrob Chemother       Date:  2013-07-12       Impact factor: 5.790

8.  CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum beta-lactamase isolated from Escherichia coli.

Authors:  L Ma; Yoshikazu Ishii; Feng-Yee Chang; Keizo Yamaguchi; Monto Ho; L K Siu
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

9.  International collaborative study on the occurrence of plasmid-mediated quinolone resistance in Salmonella enterica and Escherichia coli isolated from animals, humans, food and the environment in 13 European countries.

Authors:  Kees Veldman; Lina M Cavaco; Dik Mevius; Antonio Battisti; Alessia Franco; Nadine Botteldoorn; Mireille Bruneau; Agnès Perrin-Guyomard; Tomas Cerny; Cristina De Frutos Escobar; Beatriz Guerra; Andreas Schroeter; Montserrat Gutierrez; Katie Hopkins; Anna-Liisa Myllyniemi; Marianne Sunde; Dariusz Wasyl; Frank M Aarestrup
Journal:  J Antimicrob Chemother       Date:  2011-03-09       Impact factor: 5.790

10.  CTX-M-137, a hybrid of CTX-M-14-like and CTX-M-15-like β-lactamases identified in an Escherichia coli clinical isolate.

Authors:  Guo-Bao Tian; Ying-Min Huang; Zhi-Li Fang; Yun Qing; Xue-Fei Zhang; Xi Huang
Journal:  J Antimicrob Chemother       Date:  2014-04-28       Impact factor: 5.790

View more
  20 in total

1.  In Vivo Bioluminescent Monitoring of Therapeutic Efficacy and Pharmacodynamic Target Assessment of Antofloxacin against Escherichia coli in a Neutropenic Murine Thigh Infection Model.

Authors:  Yu-Feng Zhou; Meng-Ting Tao; Yu-Zhang He; Jian Sun; Ya-Hong Liu; Xiao-Ping Liao
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

2.  Molecular detection of Shiga toxin-producing and antibiotic-resistant Escherichia coli isolates from buffaloes in southwest of Iran.

Authors:  Sanaz Dehdashti; Reza Ghanbarpour; Mohammad Rahim Haji Hajikolaei
Journal:  Trop Anim Health Prod       Date:  2019-03-26       Impact factor: 1.559

3.  Whole Genome Characterization of the High-Risk Clone ST383 Klebsiella pneumoniae with a Simultaneous Carriage of blaCTX-M-14 on IncL/M Plasmid and blaCTX-M-15 on Convergent IncHI1B/IncFIB Plasmid from Egypt.

Authors:  Eva A Edward; Nelly M Mohamed; Azza S Zakaria
Journal:  Microorganisms       Date:  2022-05-26

4.  Clonal Spread of 16S rRNA Methyltransferase-Producing Klebsiella pneumoniae ST37 with High Prevalence of ESBLs from Companion Animals in China.

Authors:  Jing Xia; Liang-Xing Fang; Ke Cheng; Guo-Hao Xu; Xi-Ran Wang; Xiao-Ping Liao; Ya-Hong Liu; Jian Sun
Journal:  Front Microbiol       Date:  2017-03-29       Impact factor: 5.640

5.  Characteristics of NDM-1-producing Klebsiella pneumoniae ST234 and ST1412 isolates spread in a neonatal unit.

Authors:  Xu Huang; Xiangjun Cheng; Pengfei Sun; Chenjie Tang; Fang Ni; Genyan Liu
Journal:  BMC Microbiol       Date:  2018-11-14       Impact factor: 3.605

6.  Whole genome sequence analysis of Australian avian pathogenic Escherichia coli that carry the class 1 integrase gene.

Authors:  Max L Cummins; Cameron J Reid; Piklu Roy Chowdhury; Rhys N Bushell; Nicolas Esbert; Kelly A Tivendale; Amir H Noormohammadi; Shaiful Islam; Marc S Marenda; Glenn F Browning; Philip F Markham; Steven P Djordjevic
Journal:  Microb Genom       Date:  2019-01-23

Review 7.  Genomic Microbial Epidemiology Is Needed to Comprehend the Global Problem of Antibiotic Resistance and to Improve Pathogen Diagnosis.

Authors:  Ethan R Wyrsch; Piklu Roy Chowdhury; Toni A Chapman; Ian G Charles; Jeffrey M Hammond; Steven P Djordjevic
Journal:  Front Microbiol       Date:  2016-06-15       Impact factor: 5.640

Review 8.  Escherichia coli β-Lactamases: What Really Matters.

Authors:  Priyanka Bajaj; Nambram S Singh; Jugsharan S Virdi
Journal:  Front Microbiol       Date:  2016-03-30       Impact factor: 5.640

9.  Prevalence of Integrons and Insertion Sequences in ESBL-Producing E. coli Isolated from Different Sources in Navarra, Spain.

Authors:  Lara Pérez-Etayo; Melibea Berzosa; David González; Ana Isabel Vitas
Journal:  Int J Environ Res Public Health       Date:  2018-10-20       Impact factor: 3.390

10.  Emergence of Multidrug-Resistant Escherichia coli Producing CTX-M, MCR-1, and FosA in Retail Food From Egypt.

Authors:  Hazem Ramadan; Ahmed M Soliman; Lari M Hiott; Mohammed Elbediwi; Tiffanie A Woodley; Marie A Chattaway; Claire Jenkins; Jonathan G Frye; Charlene R Jackson
Journal:  Front Cell Infect Microbiol       Date:  2021-07-13       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.